Rheumatoid Arthritis News

The FDA has approved Tyenne, the second tocilizumab biosimilar overall and the first available in both intravenous and subcutaneous formulations, according to a press release from its manufacturer.

Pregnant patients with lupus or antiphospholipid syndrome have a higher risk for preterm birth, although immune-mediated inflammatory diseases in general are “only weakly associated” with adverse pregnancy outcomes, according to data.

Patients with rheumatoid arthritis — either seropositive or seronegative — demonstrate a 1.66-fold higher risk for depression vs. healthy controls, according to data published in JAMA Network Open.

The FDA has approved a supplemental new drug application for an Acthar Gel injector for the treatment of several chronic and acute inflammatory and autoimmune conditions, according to the manufacturer.

Six biomarkers were associated with baseline and treatment-associated changes in arterial inflammation in patients with rheumatoid arthritis and could be used to predict CVD risk in that population, researchers reported.

The FDA has approved Simlandi as the third interchangeable biosimilar to Humira following a rejection in April 2023 stemming from issues at the developer’s manufacturing facility.

I am thrilled to introduce our cover story this month, “‘Exploring the Power of Their Mind’: Data May Offer Clues to Harnessing the Placebo Effect,” to the readers of Healio Rheumatology. I say this for several reasons.

SCOTTSDALE, Ariz. — The Wnt signaling pathway, neutrophil extracellular traps and PRIME cells represent “extremely important” emerging targets in rheumatoid arthritis, according to a speaker here.

The U.S. Department of Veterans Affairs will replace Humira with the biosimilar Hadlima on its national formulary, according to a press release from Organon, which markets biosimilar.

SCOTTSDALE, Ariz. — Patients with rheumatoid arthritis who had a decrease in a certain type of B cell that fails to express immunoglobulin D and CD27 saw clinical improvement with abatacept, according to data presented here.